| Grace L Smith, MD | |
|
6505 Market St Bldg A, Boardman, OH 44512-3457 | |
| (330) 629-6085 | |
| (330) 629-7620 |
| Full Name | Grace L Smith |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 6505 Market St Bldg A, Boardman, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285794529 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | MD045269L (Pennsylvania) | Secondary |
| 2080P0202X | Pediatrics - Pediatric Cardiology | 35-057808 (Ohio) | Primary |
| Entity Name | Children's Hospital Medical Center Of Akron |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841328853 PECOS PAC ID: 0648183012 Enrollment ID: O20031111000484 |
News Archive
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
The University of Ottawa has earned a total of 10 Canada Research Chairs (CRCs) covering a broad scope of subjects, from the exploration of disruptive impacts of stress on higher brain functions to the need to preserve Indigenous traditional cultural memories, and emerging computing technologies that pave the way to smart cities.
Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Articulating HD 3D Laparoscopic Surgical Video System.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grace L Smith, MD 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 629-6085 | Grace L Smith, MD 6505 Market St Bldg A, Boardman, OH 44512-3457 Ph: (330) 629-6085 |
News Archive
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE (amiodarone HCL) Premixed Injection, which recently received supplemental new drug application (sNDA) approval from the U.S. Food and Drug Administration, makes use of the patent-protected CyDex Captisol technology platform.
The University of Ottawa has earned a total of 10 Canada Research Chairs (CRCs) covering a broad scope of subjects, from the exploration of disruptive impacts of stress on higher brain functions to the need to preserve Indigenous traditional cultural memories, and emerging computing technologies that pave the way to smart cities.
Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Articulating HD 3D Laparoscopic Surgical Video System.
An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.
› Verified 1 days ago
Dr. Mary Joanna Mcintyre, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St, Boardman, OH 44512 Phone: 330-746-9200 Fax: 330-746-9211 | |
Jacqueline Lee Lickliter, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St Ste 2100, Boardman, OH 44512 Phone: 330-746-8040 Fax: 330-746-8025 | |
Deanna Marie Bellville, PPCNP-BC Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St Bldg A1, Boardman, OH 44512 Phone: 330-746-8040 Fax: 330-746-8025 | |
Dr. Heather Danielle Strawbridge, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8423 Market St Ste 300, Boardman, OH 44512 Phone: 330-543-8885 Fax: 330-543-8890 | |
Hi Moon Ahn, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St, Boardman, OH 44512 Phone: 330-884-2425 | |
Dr. Stacy Lynn Generalovich, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6505 Market St Ste 2100, Boardman, OH 44512 Phone: 330-746-8040 Fax: 330-746-8025 | |
Robert Peter Vandekappelle Jr., M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 6505 Market St Fl 2, Boardman, OH 44512 Phone: 330-629-6085 Fax: 330-629-7620 |